Yves Bikorimana: Before Wash vs After Wash in Blood Grouping
Yves Bikorimana, CEO at MedData-Rwanda and Lab Scientist at The University Teaching Hospital of Kigali-Chuk, shared a post on LinkedIn:
“Before Wash vs After Wash in Blood Grouping – Why It Matters
In immunohematology, small technical details can completely change interpretation. This image perfectly demonstrates the importance of the saline wash step during blood grouping and antibody testing.
Let’s break it down
Left Side: Tube Method (Cell Washing)
Before Wash
We see a red cell suspension with plasma and possible interfering substances still present. Proteins, rouleaux formation, or excess antibodies can create pseudo-agglutination or mask true reactions.
After 3× Saline Wash plus Centrifugation
The supernatant becomes clear, and only packed red cells remain at the bottom.
Why is this important?
- Removes unbound antibodies
- Eliminates excess plasma proteins
- Prevents false reactions
- Improves accuracy of antiglobulin testing
Washing ensures we are detecting true antigen–antibody reactions, not artifacts.
Right Side: Slide/Card Agglutination (Anti-A, Anti-B, Anti-D)
Before Wash
Anti-D appears weakly positive — but note the label: False agglutination.
Sometimes:
- Rouleaux formation
- Fibrin strands
- High protein states
- Improper cell suspension
can mimic agglutination.
After Wash
The false Anti-D reaction disappears.
Result interpretation becomes clear and reliable.
- Anti-A: Negative
- Anti-B: Negative
- Anti-D: Negative
Final Blood Group: O Rh(D) Negative
Key Takeaway
In transfusion medicine, accuracy is patient safety.
A simple saline wash step can:
- Prevent mislabeling of blood groups
- Avoid incompatible transfusions
- Reduce risk of hemolytic transfusion reactions
In laboratory science, precision isn’t optional — it’s ethical responsibility.”

Stay updated with Hemostasis Today.
-
Jul 14, 2026, 11:07Mary Cushman: Honoring Outstanding Mentorship at ISTH 2026
-
Jul 14, 2026, 10:53Maha Othman: Advancing the Management of Inherited Thrombocytopenias at ISTH 2026
-
Jul 14, 2026, 10:24Sara Zalghout: The Little Things That Make ISTH 2026 Special
-
Jul 14, 2026, 10:11Joseph R. Shaw: GAUGE Advances FXa Inhibitor Reversal at ISTH 2026
-
Jul 13, 2026, 23:39Yaariv Khaykin: Whole-Person Care Can Strengthen Stroke Prevention in Patients With Atrial Fibrillation
-
Jul 13, 2026, 22:33ESOC 2026 recordings are now available on eSTEP – European Stroke Organisation
-
Jul 13, 2026, 20:17Julia R. Coleman: Fantastic First Day at ISTH 2026
-
Jul 13, 2026, 20:11Ruah Alyamany: Combination Therapy Improves Quality of Life in ITP
-
Jul 13, 2026, 19:47Brian O Mahony: Two-Year Results of BBM-H901 Gene Therapy Presented at ISTH 2026